By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said in a filing with the US Securities and Exchange Commission that it has received a $700,000 cash advance against its existing convertible promissory note facility. In connection with the advance, Helicos entered into an amendment to the subordinated secured note purchase agreement with funds affiliated with Atlas Ventures and Flagship Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.